
Merck melanoma drug shrinks tumors in 38 percent of patients
CHICAGO (Reuters) - A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with...
Home > Reviews









